Cargando…

In vitro activity of five antifungal agents against Candida albicans isolates, Sari, Iran

BACKGROUND AND PURPOSE: Candida albicans is the most common causative agent of candidiasis. Candidiasis management is dependent on the immune status of the host, severity of disease, and the choice of antifungal drug. Antifungals, specifically triazoles, are widely administered for the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shokohi, T, Badali, H, Amirrajab, N, Ataollahi, MR, Kouhpayeh, SA, Afsarian, MH
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Society of Medical Mycology 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490303/ https://www.ncbi.nlm.nih.gov/pubmed/28681018 http://dx.doi.org/10.18869/acadpub.cmm.2.2.8

Ejemplares similares

In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen
por: Amirrajab, Nasrin, et al.
Publicado: (2016)

Molecular Diversity of Candida albicans Isolated from Immunocompromised Patients, Based on MLST Method
por: AFSARIAN, Seyed Mohammad Hosein, et al.
Publicado: (2015)

Antifungal Resistance of Clinical Candida albicans Isolates in Iran: A Systematic Review and Meta-Analysis
por: Kermani, Firoozeh, et al.
Publicado: (2023)

P055 Antifungal resistance of clinical Candida albicans isolates in Iran: asystematic review and meta-analysis
por: Kermani, Firoozeh, et al.
Publicado: (2022)

In vitro antifungal potency of the moronecidin-like peptide against Candida albicans, Candida glabrata, and Candida tropicalis
por: Amirrajab, Nasrin, et al.
Publicado: (2023)

In vitro activity of four triazole antifungal drugs against clinically common and uncommon yeast species
por: Aslani, Narges, et al.
Publicado: (2019)

Susceptibility pattern of Candida albicans isolated from Iranian patients to antifungal agents
por: Badiee, P, et al.
Publicado: (2016)

In vitro activity of econazole in comparison with three common antifungal agents against clinical Candida strains isolated from superficial infections
por: Abastabar, M, et al.
Publicado: (2015)

In Vitro Susceptibilities of Candida albicans Isolates to Antifungal Agents in Tokat, Turkey
por: Yenisehirli, Gulgun, et al.
Publicado: (2015)

In Vitro Antifungal Activity of Equol against Candida albicans
por: Lee, Jeong Ah, et al.
Publicado: (2010)

Autophagy Alters the Susceptibility of Candida albicans Biofilms to Antifungal Agents
por: Shen, Jiadi, et al.
Publicado: (2023)

Isolation of Different Species of Candida in Patients With Vulvovaginal Candidiasis From Sari, Iran
por: Hedayati, Mohammad Taghi, et al.
Publicado: (2015)

Antifungal Activity of Oleuropein against Candida albicans—The In Vitro Study
por: Zorić, Nataša, et al.
Publicado: (2016)

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017)

Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
por: Rhimi, Wafa, et al.
Publicado: (2020)

In vitro evaluation of antifungal activity of monolaurin against Candida albicans biofilms
por: Seleem, Dalia, et al.
Publicado: (2016)

Antifungal Efficacy of Spice Extracts against Candida albicans: An in vitro study
por: Latti, Pooja, et al.
Publicado: (2019)

High Recovery Rate of Non-albicans Candida Species Isolated From Burn Patients With Candidemia in Iran
por: Lotfi, Nazanin, et al.
Publicado: (2015)

Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans
por: ELLEPOLA, Arjuna Nishantha, et al.
Publicado: (2015)

Characterization of Candida species isolated from vulvovaginal candidiasis by MALDI-TOF with in vitro antifungal susceptibility profiles
por: Aslani, Narges, et al.
Publicado: (2021)

Fungal Prosthetic Valve Endocarditis by Candida parapsilosis: A Case Report
por: Shokohi, Tahereh, et al.
Publicado: (2014)

Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia
por: Seyoum, Elias, et al.
Publicado: (2020)

Incidence and Antifungal Susceptibility of Candida Albicans Infections
por: UNGUREANU, A., et al.
Publicado: (2016)

Quantitative and Qualitative Analyses of the Cell Death Process in Candida albicans Treated by Antifungal Agents
por: Kim, Kyung Sook, et al.
Publicado: (2011)

Fungistatic Action of N-Acetylcysteine on Candida albicans Biofilms and Its Interaction with Antifungal Agents
por: Nunes, Thaís Soares Bezerra Santos, et al.
Publicado: (2020)

Antifungal activity of hypocrellin compounds and their synergistic effects with antimicrobial agents against Candida albicans
por: Song, Shihao, et al.
Publicado: (2020)

Cryptosporidium Infection in Patients with Gastroenteritis in Sari, Iran
por: GHOLAMI, Shirzad, et al.
Publicado: (2014)

Natural Habitat of Aureobasidium pullulans in Sari, Iran
por: Taheri Sarvtin, Mehdi, et al.
Publicado: (2015)

In vitro activities of antifungals alone and in combination with tigecycline against Candida albicans biofilms
por: Hacioglu, Mayram, et al.
Publicado: (2018)

In Vitro and In Vivo Antifungal Activity of Lichochalcone-A against Candida albicans Biofilms
por: Seleem, Dalia, et al.
Publicado: (2016)

Targeting Candida albicans in dual-species biofilms with antifungal treatment reduces Staphylococcus aureus and MRSA in vitro
por: Luo, Yu, et al.
Publicado: (2021)

Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
por: Mandras, Narcisa, et al.
Publicado: (2016)

Susceptibility of clinical Candida species isolates to antifungal agents by E-test, Southern Iran: A five year study
por: Badiee, P, et al.
Publicado: (2011)

Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles
por: Shinde, Ravikumar Bapurao, et al.
Publicado: (2013)

Inhibitors of the Glyoxylate Cycle Enzyme ICL1 in Candida albicans for Potential Use as Antifungal Agents
por: Cheah, Hong-Leong, et al.
Publicado: (2014)

D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections
por: Dartevelle, Pauline, et al.
Publicado: (2018)

Use of Haploid Model of Candida albicans to Uncover Mechanism of Action of a Novel Antifungal Agent
por: Truong, Thuyen, et al.
Publicado: (2018)

Photodynamic Inactivation Potentiates the Susceptibility of Antifungal Agents against the Planktonic and Biofilm Cells of Candida albicans
por: Huang, Mu-Ching, et al.
Publicado: (2018)

In Vitro Evaluation of Antifungal Effects of Mineral Trioxide Aggregate and Portland Cement on Candida Albicans
por: Mohammadi, Zahed, et al.
Publicado: (2006)

Evaluation of the antifungal efficacy of different concentrations of Curcuma longa on Candida albicans: An in vitro study
por: Murugesh, Jeevitha, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l129aop87jc69pgenns0h1ersm